• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis.

作者信息

Fogel Jessica M, Salih M Ali, Haddaway Kathy, Marzinke Mark A, Marshall Christi, Wang Zhe, Cummings Vanessa, Piwowar-Manning Estelle, Rooney James F, McCauley Marybeth, Grinsztejn Beatriz, Landovitz Raphael J, Eshleman Susan H

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

DNA Reference Laboratory, San Antonio, Texas, USA.

出版信息

J Clin Pathol. 2025 Jun 10. doi: 10.1136/jcp-2025-210202.

DOI:10.1136/jcp-2025-210202
PMID:40500115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287941/
Abstract
摘要

相似文献

1
Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis.使用DNA分型来确定一名正在使用注射用卡博特韦进行HIV暴露前预防的人的HIV感染状况。
J Clin Pathol. 2025 Jun 10. doi: 10.1136/jcp-2025-210202.
2
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.长效注射用卡替拉韦用于 HIV 暴露前预防的疗效、安全性、耐受性和药代动力学：HPTN 083 试验的二次分析。
Lancet HIV. 2023 Nov;10(11):e703-e712. doi: 10.1016/S2352-3018(23)00200-X. Epub 2023 Sep 29.
3
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.长效卡替拉韦与每日口服替诺福韦酯富马酸二吡呋酯/恩曲他滨相比预防无对照研究 1 年后与男性发生性行为的顺性别男性和跨性别女性感染 HIV 的疗效和安全性：HPTN 083 随机对照 2b 期和 3 期试验的二次分析。
Lancet HIV. 2023 Dec;10(12):e767-e778. doi: 10.1016/S2352-3018(23)00261-8. Epub 2023 Nov 9.
4
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.长效注射用卡博特韦用于顺性别女性青少年预防HIV的安全性、耐受性和可接受性（HPTN 084-01）：一项单臂、开放标签的2b期试验
Lancet HIV. 2025 Apr;12(4):e252-e260. doi: 10.1016/S2352-3018(24)00310-2. Epub 2025 Mar 12.
5
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis.基于 HPTN 083 和 HPTN 084 试验的南非长效注射型卡替拉韦与口服暴露前预防的相对成本效益：模型经济评估和阈值分析。
Lancet HIV. 2022 Dec;9(12):e857-e867. doi: 10.1016/S2352-3018(22)00251-X. Epub 2022 Nov 7.
6
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.卡博特韦用于女性艾滋病毒 1 型的预防：来自 HPTN 084 的结果，一项 3 期、随机临床试验。
Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1.
7
Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention.长效注射用卡博特韦作为暴露前预防与无暴露前预防措施预防HIV的间接治疗比较
Infect Dis Ther. 2025 Jul 5. doi: 10.1007/s40121-025-01172-9.
8
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.巴西男男性行为者和跨性别女性中青少年对事件驱动型和长效注射用暴露前预防药物的知晓率及使用意愿：一项横断面研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26479. doi: 10.1002/jia2.26479.
9
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.系统评价关于使用注射用暴露前预防措施预防 HIV 感染的价值观和偏好。
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26107. doi: 10.1002/jia2.26107.
10
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.在中国、澳大利亚和泰国优化男男性行为者的 HIV 暴露前预防和检测策略：一项建模研究和成本效益分析。
Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.

本文引用的文献

1
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.长效卡博特韦暴露前预防背景下的HIV感染特征
N Engl J Med. 2024 Oct 3;391(13):1253-1256. doi: 10.1056/NEJMc2402088. Epub 2024 Jul 24.
2
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.在接受注射用卡替拉韦或替诺福韦艾拉酚胺/恩曲他滨用于 HIV 预防的女性中人类免疫缺陷病毒（HIV）感染的特征：HPTN 084。
J Infect Dis. 2022 May 16;225(10):1741-1749. doi: 10.1093/infdis/jiab576.
3
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.卡博特韦用于预防顺性别男性和跨性别女性中的 HIV。
N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016.
4
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxis.长效卡替拉韦用于健康成年人 HIV 暴露前预防的多室药代动力学评价。
Br J Clin Pharmacol. 2022 Feb;88(4):1667-1678. doi: 10.1111/bcp.14980. Epub 2021 Jul 29.
5
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.接受注射用卡博特韦预防艾滋病毒的男同性恋和顺性别男性及跨性别女性中人类免疫缺陷病毒（HIV）感染的特征：HPTN 083研究
J Infect Dis. 2021 Nov 16;224(9):1581-1592. doi: 10.1093/infdis/jiab152.
6
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.长效注射型卡替拉韦在低危 HIV 未感染者中的安全性、耐受性和药代动力学：HPTN 077，一项 2a 期随机对照试验。
PLoS Med. 2018 Nov 8;15(11):e1002690. doi: 10.1371/journal.pmed.1002690. eCollection 2018 Nov.
7
Genetics and genomics of core short tandem repeat loci used in human identity testing.用于人类身份鉴定的核心短串联重复序列位点的遗传学与基因组学
J Forensic Sci. 2006 Mar;51(2):253-65. doi: 10.1111/j.1556-4029.2006.00046.x.
8
Resolution of a serum sample mix-up through the use of short tandem repeat DNA typing.
Transfusion. 2004 Dec;44(12):1750-4. doi: 10.1111/j.0041-1132.2004.04212.x.